The treatment of melanoma cell lines A375- and MeWo-WT, with maximum 30 μM of TG2 inhibitor I1 for up to 72 h, revealed neither cytotoxic effects nor impairment of the cell viability (Figure 4B). The gene discussed is TGM2; the disease is melanoma.